RAPP Competitors & Alternatives
Compare Rapport Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RAPP
Main Stock$25.93
Tradestie Score
54
Market Cap
$1.32B
Analyst Upside
+167.9%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.40
|
$1.35B | - | 59 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.20
|
$1.29B | - | 44 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.04
|
$1.29B | - | 53 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.08
|
$1.29B | - | 57 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.22
|
$1.28B | - | 47 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.57
|
$1.27B | - | 58 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.19
|
$1.18B | - | 62 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$41.52
|
$1.17B | - | 65 | Compare |
More RAPP Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry